Latest Breaking News On - Biosciences investor contact - Page 7 : comparemela.com

HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC

HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLuis sanayParagon biosciencesXylophone acquisition corpExchange commissionZynerba pharmaceuticals incHarmony biosciences holdings incHarmony biosciences holdingsZynerba pharmaceuticalsYork cityHarmony biosciencesLooking statementsPrivate securities litigation reform actUnited states securitiesXylophone acquisition

HARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M DAYNO, M D , NAMED TO 2023 PHARMAVOICE 100 LIST OF TOP INDUSTRY LEADERS

/PRNewswire/ Jeffrey M. Dayno, M.D., President & CEO of Harmony Biosciences, was named to the 2023 PharmaVoice 100 list for his unwavering commitment to.

Plymouth meetingUnited statesLuis sanayEmalex biosciencesPrnewswire jeffreyParagon biosciencesCentral nervous system drugs advisory committeeJefferson medical collegeHarmony biosciences holdings incHarmony biosciencesBiosciences holdingsChief medical officerChief executive officerIndustry representativeLife science cares philadelphiaLewis katz school

HARMONY BIOSCIENCES TO PARTICIPATE IN 2023 CANTOR GLOBAL HEALTHCARE CONFERENCE

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and.

New yorkUnited statesLuis sanayPrnewswire harmony biosciences holdings incParagon biosciencesCompany nasdaqBiosciences holdingsGlobal healthcare conferenceHarmony biosciencesPlymouth meetingBiosciences investor contactBiosciences media contactHealth care amp hospitalsMedical pharmaceuticalsTrade show news

HARMONY BIOSCIENCES ANNOUNCES US FOOD & DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT FOR TREATMENT OF IDIOPATHIC HYPERSOMNIA

PLYMOUTH MEETING, Pa., Sept. 7, 2023 /PRNewswire/ Harmony Biosciences Holdings, Inc. , a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients.

Kumar budurLuis sanayDrug administrationParagon biosciencesHarmony biosciences holdings incExchange commissionHarmony biosciences holdingsOrphan drugChief medical officerHarmony biosciencesPlymouth meetingPrivate securities litigation reform actAnnual reportBiosciences media contactBiosciences investor contact

HARMONY BIOSCIENCES REITERATES CONFIDENCE IN WAKIX® (PITOLISANT) PATENTS FOLLOWING FAVORABLE DECISION BY U S PATENT AND TRADEMARK OFFICE (USPTO) TO DENY PETITION FOR REEXAMINATION

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and.

United statesLuis sanayDrug administrationPrnewswire harmony biosciences holdings incCompany nasdaqExchange commissionParagon biosciencesTrademark officeBiosciences holdingsFull prescribing informationHarmony biosciencesPlymouth meetingPrivate securities litigation reform actAnnual reportBiosciences investor contactBiosciences media contact